Torrent Pharmaceuticals in partnership with Novo Nordisk has inaugurated an enhanced facility in Gujarat and looking at launching more new products in India. With the inauguration of second phase of the manufacturing facility at Indrad in Gujarat, it will increase insulin producing capacity by 35% to meet the growing demand.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
